Key Highlights
•
A new blood test based on 32 proteins can predict who will develop chronic obstructive pulmonary disease (COPD) with high accuracy, outperforming genetic risk scores. This tool could allow doctors to identify high-risk individuals earlier and explore new treatment targets related to inflammation and tissue remodeling.
Source →
•
A streamlined 10-protein version of the test retained strong predictive power, making it a more feasible option for clinical use. Adding this protein score to standard clinical assessments significantly improved doctors’ ability to correctly reclassify a patient’s risk of developing COPD.
Source →
•
For women aged 65 and older, HPV-based testing and self-sampling methods are effective for catching cervical cancer, especially in those who missed earlier screenings. A Danish program using these methods saw a huge increase in participation and detected significantly more pre-cancerous cases compared to standard practice.
Source →
•
Self-sampling for HPV, including newer mRNA-based tests, is a practical option for older women and can help overcome barriers like discomfort during a traditional exam. This approach supports updating screening guidelines to use risk-informed, HPV-based strategies for women beyond the typical stopping age.
Source →
•
Distinct patterns of inflammation in the blood, measured by cytokines and other proteins, are linked to different stages of Alzheimer’s disease, whether or not amyloid plaques are present. This discovery points to inflammation as a key player throughout the disease process and highlights potential new biomarkers for tracking its progression.
Source →
•
The study identified a core set of inflammatory markers that change with cognitive decline independently of amyloid, and a broader set that is specific to amyloid-positive cases, implicating specific immune cell pathways. These blood-based profiles could serve as valuable tools for research and future clinical trials targeting the immune system in Alzheimer’s.
Source →
•
A study of nearly 28,000 people found that a protein-based risk score was far better at predicting new cases of COPD than a score based on genetics alone. The analysis also pinpointed specific proteins that either protect against or increase COPD risk, revealing new potential targets for drug development.
Source →
•
Research shows that clinically significant HPV infections and pre-cancerous lesions are found in women over 65, particularly if their prior screening was incomplete. This evidence challenges the traditional one-size-fits-all exit age for cervical cancer screening and argues for more personalized, risk-based approaches.
Source →
•
In Alzheimer’s disease, the relationship between specific immune markers and brain health is complex, with some markers paradoxically linked to better memory in certain contexts. This underscores the need for more research to understand the precise, stage-specific roles of inflammation, which could lead to better diagnostic and treatment strategies.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
